ReP USP - Resultado da busca

Artigo de periodico
ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) (2019)
Fernandes, Débora Kristina Alves; Oliveira, Erica Aparecida de; Flores, Fernanda Faião; Rebecca, Gretchen Alicea; Weeraratna, Ashani T; Smalley, Keiran S. M; Barros, Silvia Berlanga de Moraes ; Maria-Engler, Silvya Stuchi
Source: Pharmacological Research. Unidade: FCF
Subjects: MELANOMA, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Débora Kristina Alves et al. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC). Pharmacological Research, v. 141, p. 63-72, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2018.12.006. Acesso em: 05 nov. 2024.
APA
Fernandes, D. K. A., Oliveira, E. A. de, Flores, F. F., Rebecca, G. A., Weeraratna, A. T., Smalley, K. S. M., et al. (2019). ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC). Pharmacological Research, 141, 63-72. doi:10.1016/j.phrs.2018.12.006
NLM
Fernandes DKA, Oliveira EA de, Flores FF, Rebecca GA, Weeraratna AT, Smalley KSM, Barros SB de M, Maria-Engler SS. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) [Internet]. Pharmacological Research. 2019 ; 141 63-72.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.phrs.2018.12.006
Vancouver
Fernandes DKA, Oliveira EA de, Flores FF, Rebecca GA, Weeraratna AT, Smalley KSM, Barros SB de M, Maria-Engler SS. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) [Internet]. Pharmacological Research. 2019 ; 141 63-72.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.phrs.2018.12.006
Artigo de periodico
Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma (2014)
Rebecca, Vito William; Massaro, Renato Ramos; Fedorenko, Inna V; Sondak, Vernon K; Anderson, Alexander R. A; Kim, Eunjung; Amaravadi, Ravi K; Maria-Engler, Silvya Stuchi ; Messina, Jane L; Gibney, Geoffrey T; Kudchadkar, Ragini R; Smalley, Keiran S. M
Source: Pigment Cell Melanoma Research. Unidade: FCF
Subjects: QUIMIOTERAPIA, MELANOMA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBECCA, Vito William et al. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, v. 27, n. 3, p. 465-478, 2014Tradução . . Disponível em: https://doi.org/10.1111/pcmr.12227. Acesso em: 05 nov. 2024.
APA
Rebecca, V. W., Massaro, R. R., Fedorenko, I. V., Sondak, V. K., Anderson, A. R. A., Kim, E., et al. (2014). Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Research, 27( 3), 465-478. doi:10.1111/pcmr.12227
NLM
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/pcmr.12227
Vancouver
Rebecca VW, Massaro RR, Fedorenko IV, Sondak VK, Anderson ARA, Kim E, Amaravadi RK, Maria-Engler SS, Messina JL, Gibney GT, Kudchadkar RR, Smalley KSM. Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma [Internet]. Pigment Cell Melanoma Research. 2014 ; 27( 3): 465-478.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/pcmr.12227
Artigo de periodico
Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach (2013)
Kim, Eunjung; Rebecca, Vito William; Fedorenko, Inna V; Messina, Jane L; Mathew, Rahel; Maria-Engler, Silvya Stuchi ; Basanta, David; Smalley, Keiran S. M; Anderson, Alexander R. A
Source: Cancer Research. Unidade: FCF
Subjects: FIBROBLASTOS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIM, Eunjung et al. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Research, v. 73, n. 23, p. 6874-6885, 2013Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.can-13-1720. Acesso em: 05 nov. 2024.
APA
Kim, E., Rebecca, V. W., Fedorenko, I. V., Messina, J. L., Mathew, R., Maria-Engler, S. S., et al. (2013). Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Research, 73( 23), 6874-6885. doi:10.1158/0008-5472.can-13-1720
NLM
Kim E, Rebecca VW, Fedorenko IV, Messina JL, Mathew R, Maria-Engler SS, Basanta D, Smalley KSM, Anderson ARA. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach [Internet]. Cancer Research. 2013 ; 73( 23): 6874-6885.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1158/0008-5472.can-13-1720
Vancouver
Kim E, Rebecca VW, Fedorenko IV, Messina JL, Mathew R, Maria-Engler SS, Basanta D, Smalley KSM, Anderson ARA. Senescent Fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach [Internet]. Cancer Research. 2013 ; 73( 23): 6874-6885.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1158/0008-5472.can-13-1720

USP Schools

ReP

Filtros

Authors

Non normalized affiliation